Skip to content

The development of a new type of accurate radiotherapy positioning system for head and neck cancer

The development of a new type of accurate radiotherapy positioning system for head and neck cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-HNC-17012016
Enrollment
Unknown
Registered
2017-07-17
Start date
2017-06-26
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

Bite fixing:using a new bite fixing device

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with hand and neck cancer, who need precision radiotherapy for multiple times; 2. Intensity modulated radiotherapy (IMRT) is expected to be applied; 3. Patients with clear consciousness who can cooperate with setup and treatment; 4. Eastern Cooperative Oncology Group Performance Status Scale (ECOG-PS) =2; 5. Aged 18 years or elder; non-pregnant women; 6. Agree to participate in necessary examination and follow-up for research purpose and to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with trismus or dyspnea with opening mouth who cannot cooperate with treatment; 2. Patients with few teeth or are toothless, for whom 3D printed biting device cannot be made; 3. Patients with eyeball fixed or blinded who cannot cooperate with treatment; 4. Eastern Cooperative Oncology Group Performance Status Scale (ECOG-PS) >2; 5. Patients with severe mental disease or psychological obstacle, or dysfunction of the central nervous system, or cardio-cerebrovascular complications, or epilepsy etc. Patients with poor compliance or cannot provide written informed consent; 6. Cannot cooperate with treatment for other reasons; 7. Pregnant women or breast-feeding women; fertile women with urine or blood pregnant tests positive two weeks before inclusion or fertile women without reliable contraceptive measures; 8. Patients with severe and uncontrolled infectious diseases; 9. Patients with other uncontrolled diseases which may affect the study.

Design outcomes

Primary

MeasureTime frame
Set-up error;

Countries

China

Contacts

Public ContactZhang Min

Peking University First Hospital

mincoin@qq.com+86 13811203207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026